News & Updates
Showing Multidisciplinary articles
Showing

Dolutegravir knocks down HIV faster than bictegravir in French study
Final analysis of the BicDol study, presented at AIDS 2026, suggests that a first-line triple antiretroviral regimen containing dolutegravir suppresses HIV more rapidly than one containing bictegravir, particularly among patients with the highest viral loads.

Antibiotic use ups risk of IBD flare-ups
Use of antibiotics for nongastrointestinal (non-GI) infections results in a three- to fivefold increase in the risk of inflammatory bowel disease (IBD) flare-ups, a study has found. The risk gradually declines and returns to baseline level about 6 weeks after exposure.

Fewer major bleeds with prasugrel as default antiplatelet after PCI
When prasugrel is the default antiplatelet for patients with acute coronary syndromes (ACS) undergoing PCI*, fewer major bleeds occur than when ticagrelor is the default, according to the SWITCH-SWEDEHEART study presented at ESC 2026. This benefit is not accompanied by increased ischaemic events.





